Determining b-lactam exposure threshold to suppress resistance development in Gram-negative bacteria
Vincent H. Tam, Kai-Tai Chang, Jian Zhou, Kimberly R. Ledesma, Kady Phe, Song Gao, Françoise Van Bambeke, Ana Maria Sanchez-Dıaz, Laura Zamorano, Antonio Oliver and Rafael Canton
J Antimicrob Chemother 2017; 72: 1421–1428
DOI: 10.1093/jac/dkx001
PDF
Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/ pharmacodynamics targets: are first conventional doses effective?
Isabelle K. Delattre, Fabio S. Taccone, Frédérique Jacobs, Maya Hites, Thierry Dugernier, Herbert Spapen, Pierre-François Laterre, Pierre E. Wallemacq, Françoise Van Bambeke & Paul M. Tulkens
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2017 VOL. 15, NO. 7, 677–688
Prevalence of extended-spectrum beta-lactamase and carbapenemase-producing bloodstream isolates of Klebsiella pneumoniae in a tertiary care hospital
Henrietta Abodakpi, Kai-Tai Chang, Ana María Sánchez Díaz, Rafael Cantón, Todd M. Lasco, Katrina Chan, Amelia K. Sofjan & Vincent H. Tam
Journal of Chemotherapy, 2018 VOL. 30, NO. 2, 115-119
Optimal Piperacillin-Tazobactam Dosing Strategies against Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
Henrietta Abodakpi, Kai-Tai Chang, Song Gao, Ana María Sánchez-Díaz, Rafael Cantón, Vincent H. Tam
Antimicrob Agents Chemother. 2019 Jan 29;63(2)
DOI: 10.1093/jac/dkx001